-

Biotech Proteintech announces new line of highly validated conjugated antibodies

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, the benchmark in antibodies and proteins, announces the launch of over 500 antibodies directly conjugated with high-performance CoraLite®488 and CoraLite®594 dyes.

The rapid expansion of biomarkers and microscopic methods has led to an increased demand for multiplex imaging of specific proteins. Unfortunately, it is technically challenging to image using more than 2 unconjugated antibodies. To solve this issue, Proteintech now offers its same KD/KO validated and highly published antibodies in an off-the-shelf directly conjugated form to CoraLite® dyes.

“It is great to be able to save our customers’ time by offering our highly validated products that are conjugated for their immediate use,” said Jeff Lee, Proteintech Chief Operating Officer, “we plan to continue to grow this portfolio with daily launches of new conjugations.”

Proteintech’s CoraLite® conjugated antibodies have the most validation in the market, including genetic manipulation to confirm specificity. Having highly validated, specific antibodies directly conjugated to dyes simplifies multiplex imaging and accelerates the immunostaining procedure. CoraLite® dyes fluoresce at the most frequently excitation wavelengths of 488 and 594 nm to integrate easily into the majority of fluorescent microscope workflows. They are high performance dyes with identical activity as the leading competitor. For a product listing, please visit ptglab.com/products/coralite-fluorescent-dye-conjugated-antibodies/.

About Proteintech Group

Proteintech is an antibody manufacturer selling directly to scientists and only selling its own products to maintain the highest level of quality control leading to superior reproducibility and lot consistency. With over 2/3 of the human genome completed, we have a catalog of over 12,000 antibodies against 12,000 targets covering almost complete spectrum of research areas. With its acquisition of Humanzyme, Proteintech now offers the Humankine product line of animal-free human-cell expressed proteins. To view tens of thousands of publications and in-house validation images in WB, IHC, IF, FC, IP, CHIP, Knock-down siRNA using our antibodies and to learn more about Proteintech and their mission to deliver products directly from their bench to the researcher’s bench, please visit www.ptglab.com

Contacts

Proteintech Group, Inc.
Katie Bellows
Katie@ptglab.com

Proteintech Group, Inc.


Release Summary
Biotech Proteintech announces new line of highly validated conjugated antibodies
Release Versions

Contacts

Proteintech Group, Inc.
Katie Bellows
Katie@ptglab.com

Social Media Profiles
More News From Proteintech Group, Inc.

Proteintech Launches “Able” AI – A First-of-Its-Kind Tool to Accelerate Scientific Discovery

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, today announced the launch of Able AI, a first-of-its-kind artificial intelligence tool that is now available on ptglab.com. Finding the most suitable antibodies from the vast pool of potential products is a challenge. Able helps scientists pinpoint the right antibody based on their research needs, while also providing all relevant information and associated scientific knowledge. In addition,...

Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its website (ptglab.com). The advanced validation data, 3D Epitope Mapping, is designed to enhance the efficiency and accuracy of antibody-related selection, empowering scientists with the data they need to advance their work, from basic research to the design of novel therapeutics. The 3D Epitope Mappi...

Proteintech Genomics Launches the MultiPro® Human Discovery Panel: A New Frontier in Single-Cell Multiomics

SAN DIEGO--(BUSINESS WIRE)--Proteintech Genomics, a leader in antibody-based multiplexed solutions for single-cell multiomics, today announced the launch of its MultiPro® Human Discovery Panel, a groundbreaking antibody panel designed to transform single-cell multiomics research. This new panel enables scientists to profile 325 proteins alongside whole transcriptome analysis within single cells, offering a multiomic approach that delivers deeper insights into cellular functions. The MultiPro® H...
Back to Newsroom